Bay Colony Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.66M | Sell |
20,685
-10,387
| -33% | -$1.22M | 0.29% | 67 |
|
|
2026
Q1 | $3.74M | Buy |
31,072
+2,180
| +8% | +$252K | 0.46% | 45 |
|
|
2025
Q4 | $3.04M | Buy |
28,892
+1,592
| +6% | +$149K | 0.36% | 53 |
|
|
2025
Q3 | $2.29M | Sell |
27,300
-1,726
| -6% | -$142K | 0.27% | 77 |
|
|
2025
Q2 | $2.3M | Buy |
29,026
+644
| +2% | +$51.2K | 0.32% | 67 |
|
|
2025
Q1 | $2.53M | Sell |
28,382
-2,082
| -7% | -$194K | 0.39% | 58 |
|
|
2024
Q4 | $3.03M | Sell |
30,464
-3,907
| -11% | -$403K | 0.45% | 47 |
|
|
2024
Q3 | $3.9M | Sell |
34,371
-179
| -0.5% | -$21.3K | 0.59% | 33 |
|
|
2024
Q2 | $4.28M | Sell |
34,550
-335
| -1% | -$43.2K | 0.71% | 27 |
|
|
2024
Q1 | $4.6M | Buy |
34,885
+5
| +0% | +$616 | 0.81% | 24 |
|
|
2023
Q4 | $3.8M | Buy |
34,880
+1,959
| +6% | +$203K | 0.75% | 25 |
|
|
2023
Q3 | $3.39M | Sell |
32,921
-988
| -3% | -$106K | 0.82% | 22 |
|
|
2023
Q2 | $3.91M | Sell |
33,909
-1,183
| -3% | -$134K | 0.94% | 20 |
|
|
2023
Q1 | $3.72M | Sell |
35,092
-2,302
| -6% | -$249K | 0.98% | 17 |
|
|
2022
Q4 | $4.15M | Buy |
37,394
+76
| +0.2% | +$7.77K | 1.09% | 16 |
|
|
2022
Q3 | $3.21M | Buy |
37,318
+1,925
| +5% | +$172K | 0.95% | 17 |
|
|
2022
Q2 | $3.16M | Buy |
35,393
+622
| +2% | +$55.1K | 0.81% | 22 |
|
|
2022
Q1 | $2.85M | Buy |
34,771
+3,878
| +13% | +$306K | 0.68% | 30 |
|
|
2021
Q4 | $2.37M | Buy |
30,893
+525
| +2% | +$41.8K | 0.68% | 31 |
|
|
2021
Q3 | $2.28M | Buy |
30,368
+419
| +1% | +$31.9K | 0.75% | 28 |
|
|
2021
Q2 | $2.33M | Buy |
29,949
+359
| +1% | +$26.7K | 0.78% | 23 |
|
|
2021
Q1 | $2.18M | Buy |
29,590
+15,891
| +116% | +$1.17M | 0.83% | 23 |
|
|
2020
Q4 | $1.07M | Buy |
13,699
+640
| +5% | +$48.9K | 0.57% | 53 |
|
|
2020
Q3 | $1.03M | Buy |
13,059
+2,606
| +25% | +$204K | 0.64% | 49 |
|
|
2020
Q2 | $771K | Buy |
10,453
+1,020
| +11% | +$76.8K | 0.56% | 59 |
|
|
2020
Q1 | $693K | Buy |
9,433
+74
| +0.8% | +$5.82K | 0.63% | 53 |
|
|
2019
Q4 | $801K | Buy |
9,359
+909
| +11% | +$74.7K | 0.52% | 58 |
|
|
2019
Q3 | $679K | Buy |
8,450
+4,250
| +101% | +$341K | 0.46% | 73 |
|
|
2019
Q2 | $336K | Sell |
4,200
-453
| -10% | -$34.7K | 0.22% | 131 |
|
|
2019
Q1 | $367K | Buy |
4,653
+1,057
| +29% | +$79.1K | 0.24% | 111 |
|
|
2018
Q4 | $262K | Sell |
3,596
-510
| -12% | -$36K | 0.22% | 120 |
|
|
2018
Q3 | $278K | Buy |
4,106
+399
| +11% | +$25.4K | 0.21% | 138 |
|
|
2018
Q2 | $215K | Buy |
+3,707
| New | +$209K | 0.15% | 142 |
|
Other funds holding MRK
ECSS
Bay Colony Advisors's MRK Position: Q2 2026 in Review
Bay Colony Advisors reduced its Merck (MRK) stake by 33% in Q2 2026, selling an estimated $1.22M and leaving 20,685 shares worth $2.66M. The position accounts for 0.29% of the portfolio, ranked #67.
Bay Colony Advisors first reported a position in MRK in Q2 2018 and has held it in 33 quarters since. The position peaked at $4.6M in Q1 2024. 1,672 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Bay Colony Advisors held 20,685 shares of Merck worth $2.66M as of Q2 2026.
- Bay Colony Advisors sold 10,387 Merck shares in Q2 2026, an estimated $1.22M.
- Merck made up 0.29% of Bay Colony Advisors's portfolio in Q2 2026, its #67 holding.
- Bay Colony Advisors first reported a position in Merck in Q2 2018 and has held it in 33 quarters since.
- Bay Colony Advisors's Merck position peaked at $4.6M in Q1 2024.
- 1,672 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.